SHOULD ANTIBODIES TO DOMAIN I B2-GLYCOPROTEIN 1 BE INVESTIGATED IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME (APS) AND SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)?

被引：1
|
作者：
Cheldieva, F. [1 ,2 ]
Reshetnyak, T. [1 ,2 ]
Cherkasova, M. [1 ]
Glukhova, S. [3 ]
Lila, A. [2 ]
Nasonov, E. [3 ]
机构：
[1] VA Nasonova Res Inst Rheumatol, Lab Thromboinflammat, Moscow, Russia
[2] Minist Hlth Russia, Russian Med Acad Continuing Profess Educ, Dept Rheumatol, Moscow, Russia
[3] VA Nasonova Res Inst Rheumatol, Dept Rheumatol, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.2329
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0496
引用
收藏
页码：1374 / 1375
页数：2
相关论文
共 50 条
  • [41] Prevalence and isotype distribution of antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus (SLE)
    Aguirre, V
    Cuchacovich, R
    Barria, L
    Aris, H
    Trejo, C
    Massardo, L
    Pasten, R
    Espinoza, L
    LUPUS, 2001, 10 (02) : 75 - 80
  • [42] The antiphospholipid/cofactor syndromes .2. A variant in patients with systemic lupus erythematosus with antibodies to beta(2)-glycoprotein I but no antibodies detectable in standard antiphospholipid assays
    AlarconSegovia, D
    Mestanza, M
    Cabiedes, J
    Cabral, AR
    JOURNAL OF RHEUMATOLOGY, 1997, 24 (08) : 1545 - 1551
  • [43] Clinical features and pattern of Antiphospholipid antibodies in patients of antiphospholipid syndrome with Systemic Lupus Erythematosus
    SheharbanoImran
    Taj, Sadia
    Ahmed, Qasim
    Din, Zia Ud
    Faiq, Muhammad
    Khan, Asadullah
    RAWAL MEDICAL JOURNAL, 2023, 48 (02): : 343 - 347
  • [44] IgG anti-β2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus:: Prevalence and diagnostic value for the antiphospholipid syndrome
    Tubach, F
    Hayem, G
    Marchand, JL
    Weber, M
    Palazzo, E
    de Bandt, M
    Roux, S
    Kahn, MF
    Meyer, O
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (06) : 1437 - 1443
  • [45] Anticardiolipin and anti-beta 2 glycoprotein-I antibodies disappearance in patients with systemic lupus erythematosus and antiphospholipid syndrome while on belimumab
    Sciascia, Savino
    Rubini, Elena
    Radin, Massimo
    Cecchi, Irene
    Rossi, Daniela
    Roccatello, Dario
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (11) : 1693 - +
  • [46] Antiβ2-glikoprotein I antibodies in diagnostics of secondary antiphospholipid syndrome in systemic lupus erythematosus patients
    Ostanek, L
    Brzosko, M
    Fischer, K
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 208 - 208
  • [47] Obstetric outcome in systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS): The St Thomas' Hospital lupus in pregnancy clinic experience
    Khamashta, MA
    Buchanan, NMM
    Lima, F
    Kerslake, S
    Hunt, BI
    Hughes, GRV
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1059 - 1059
  • [48] PREVALENCE OF BETA(2)-GLYCOPROTEIN-I ANTIBODY IN SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS WITH BETA(2)-GLYCOPROTEIN-I DEPENDENT ANTIPHOSPHOLIPID ANTIBODIES
    MATSUDA, J
    SAITOH, N
    GOTOH, M
    GOHCHI, K
    TSUKAMOTO, M
    ANNALS OF THE RHEUMATIC DISEASES, 1995, 54 (01) : 73 - 75
  • [49] Clinical significance of antiphospholipid syndrome nephropathy (APSN) in patients with systemic lupus erythematosus (SLE)
    Miranda, Juan M.
    Jara, Luis J.
    Calleja, Concepcion
    Saavedra, Miguel A.
    Bustamante, Reyna M.
    Angeles, Ulises
    REUMATOLOGIA CLINICA, 2009, 5 (05): : 209 - 213
  • [50] Prevalence and isotype distribution of antiphospholipid antibodies (aPL) in Chilean patients with systemic lupus erythematosus (SLE).
    Aguirre, VI
    Cuchacovich, R
    Mendez, EA
    Cucurrull, E
    de Leon, JHP
    Espinoza, LR
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (01) : 106A - 106A
12345